SAGE THERAPEUTICS INC (SAGE)
US78667J1088 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -503.17M | -541.49M | -532.80M | -457.90M | 606.10M | |||
| Depreciation Amortization | 1.43M | 1.39M | 1.10M | 4.20M | 2.60M | |||
| Change In Working Capital | 14.81M | -67.38M | 5.70M | -18.50M | -39.70M | |||
| Other non cash items | 62.22M | 66.89M | 66.00M | 94.00M | 95.30M | |||
| OPERATING CASH FLOW | -424.72M | -540.59M | -460.00M | -378.20M | 664.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -353.00K | -553.00K | -900.00K | -400.00K | -300.00K | |||
| Other Investing Activity | 387.80M | 443.47M | 326.40M | -1.00B | 443.00M | |||
| INVESTING CASH FLOW | 387.45M | 442.91M | 325.40M | -1.00B | 442.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 5.19M | 6.93M | 3.10M | 14.70M | 426.80M | |||
| Other Financing Activity | -305.00K | -903.00K | 0.00 | -1.40M | N/A | |||
| FINANCING CASH FLOW | 4.88M | 6.03M | 3.10M | 13.30M | 426.80M | |||
| CHANGE IN CASH | -32.38M | -91.65M | -131.50M | -1.37B | 1.53B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -424.72M | -540.59M | -460.00M | -378.20M | 664.30M | |||
| Capital Expenditure | -353.00K | -553.00K | -900.00K | -400.00K | -300.00K | |||
| FREE CASH FLOW | -425.07M | -541.14M | -460.90M | -378.60M | 664.00M | |||
All data in USD